Hebei Rimao Technology
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Hebei Rimao Technology between 11 Aug 2025 and 4 Sep 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Hebei Rimao Technology
Retatrutide
Tested 3 Samples
Last test 4 Sep 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Hebei Rimao Technology
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
4 Sep 2025
First
11 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Sep 2025 | View | 5mg | 4.920mg | -1.6% | 99.95% | (no batch ID) | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 12 Aug 2025 | View | 10mg | 10.910mg | +9.1% | 98.35% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab A | Public | |
| 11 Aug 2025 | View | 30mg | 30.100mg | +0.3% | 99.95% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab E | Public | |